Attached files

file filename
EX-31.2 - EX-31.2 - Cullinan Oncology, Inc.cgem-ex312_8.htm
EX-31.1 - EX-31.1 - Cullinan Oncology, Inc.cgem-ex311_9.htm
EX-23.1 - EX-23.1 - Cullinan Oncology, Inc.cgem-ex231_521.htm
EX-4.3 - EX-4.3 - Cullinan Oncology, Inc.cgem-ex43_384.htm
EX-4.2 - EX-4.2 - Cullinan Oncology, Inc.cgem-ex42_520.htm
EX-3.2 - EX-3.2 - Cullinan Oncology, Inc.cgem-ex32_385.htm
EX-3.1 - EX-3.1 - Cullinan Oncology, Inc.cgem-ex31_386.htm
10-K - 10-K - Cullinan Oncology, Inc.cgem-10k_20201231.htm

Exhibit 32.1

 

CERTIFICATIONS OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Cullinan Oncology, Inc. (the “Company”) on Form 10-K for the period ending December 31, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned hereby certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to the best of their knowledge:

 

(1)

The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

Date: March 30, 2021

 

By:

/s/ Owen Hughes

 

 

 

Owen Hughes

 

 

 

President and Chief Executive Officer

(Principal Executive Officer)

 

Date: March 30, 2021

 

By:

/s/ Jeffrey Trigilio

 

 

 

Jeffrey Trigilio

 

 

 

Chief Financial Officer

(Principal Financial and Accounting Officer)

 

 

1

ACTIVE/108795781.1